Acceder Registro /

BARTOLOMÉ CARRILERO FERNÁNDEZ

Buscador

Murcia L, Carrilero B, Segovia M. Limitations of currently available Chagas disease chemotherapy. Rev Esp Quimioter. 2012 Mar;25(1):1-3. PubMed PMID: 22488534.
AÑO: 2012; IF: 0.836
Iborra MA, García E, Carrilero B, Segovia M. [Malaria diagnosis and treatment: analysis of a cohort of hospitalised patients at a tertiary level hospital (1998-2010)]. Rev Esp Quimioter. 2013 Mar;26(1):6-11. Spanish. PubMed PMID: 23546456.
AÑO: 2013; IF: 0.905
Murcia L, Carrilero B, Saura D, Iborra MA, Segovia M. [Diagnosis and treatment of Chagas disease]. Enferm Infecc Microbiol Clin. 2013 Feb;31 Suppl 1:26-34. doi: 10.1016/S0213-005X(13)70111-3. Spanish. PubMed PMID: 23453228.
AÑO: 2013; IF: 1.881
Fernández-Villegas A, Thomas MC, Carrilero B, Téllez C, Marañón C, Murcia L, Moralo S, Alonso C, Segovia M, López MC. The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country. Acta Trop. 2014 Dec;140:84-90. doi: 10.1016/j.actatropica.2014.08.006. PubMed PMID: 25149352.
AÑO: 2014; IF: 2.27
Egui A, Thomas MC, Carrilero B, Segovia M, Alonso C, Marañón C, López MC. Differential phenotypic and functional profiles of TcCA-2 -specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in Chagasic patients. PLoS One. 2015 Mar 27;10(3):e0122115. doi: 10.1371/journal.pone.0122115. PubMed PMID: 25816096; PubMed Central PMCID: PMC4376724.
AÑO: 2015; IF: 3.057

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R